Literature DB >> 17495362

Peripancreatic tuberculous lymphadenopathy. An impostor posing diagnostic difficulty.

Jijo Velliyappillil Cherian1, Aravindh Somasundaram, Rajesh Prabhu Ponnusamy, Jayanthi Venkataraman.   

Abstract

CONTEXT: Involvement of the peripancreatic lymph nodes by tuberculosis is rare and the clinical presentation varies. It can mimic cystic neoplasms of the pancreas. CASE REPORT: We report the case of a patient having peripancreatic tuberculosis who presented with fever, jaundice, supraclavicular lymphadenopathy and weight loss. Imaging and tumor markers also suggested a pancreatic malignancy. MRI helped to identify the peripancreatic lymph node involvement and biopsy of the supraclavicular lymph node clinched the diagnosis.
CONCLUSION: Pancreatic and peripancreatic tuberculosis should be considered in the differential diagnosis of cystic lesions of the head of the pancreas.

Entities:  

Mesh:

Year:  2007        PMID: 17495362

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  3 in total

1.  Tuberculous lymphadenopathy mimicking pancreatic neoplasm.

Authors:  Kunikazu Hoshino; Shingo Arakaki; Daisuke Shibata; Tatsuji Maeshiro; Akira Hokama; Fukunori Kinjo; Masayuki Shiraishi; Tadashi Nishimaki; Jiro Fujita
Journal:  Case Rep Med       Date:  2012-07-19

2.  An HIV-positive Case of Obstructive Jaundice Caused by Immune Reconstitution Inflammatory Syndrome of Tuberculous Lymphadenitis Successfully Treated with Corticosteroids.

Authors:  Naoaki Watanabe; Ryota Sato; Hideaki Nagai; Hirotoshi Matsui; Akira Yamane; Masahiro Kawashima; Junko Suzuki; Hiroyuki Tashimo; Nobuharu Ohshima; Kimihiko Masuda; Atsuhisa Tamura; Shinobu Akagawa; Akira Hebisawa; Ken Ohta
Journal:  Intern Med       Date:  2017-09-06       Impact factor: 1.271

Review 3.  Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: a case report and literature review.

Authors:  Dajun Yu; Xiaolan Li; Jianping Gong; Jinzheng Li; Fei Xie; Jiejun Hu
Journal:  BMC Gastroenterol       Date:  2020-08-18       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.